Suggestions
Paul Christie
Chief Executive Officer at Tachmed
Paul Christie is the Group Chief Executive Officer of Tachmed, a health technology company with operations in both the USA and the UK. Under his leadership since January 2019, Tachmed is focused on developing innovative home-based rapid diagnostic solutions aimed at transforming healthcare accessibility and efficiency. The company’s products are designed to allow individuals to self-test for various health conditions, including COVID-19, from the comfort of their homes, thereby streamlining the healthcare process and reducing reliance on traditional medical appointments.13
Background and Experience
Paul Christie has a diverse background as an entrepreneur and investor, having advised multinational businesses across various sectors. His professional journey includes previous roles such as:
- Investor at iBio Health (2017-2018)
- Founding Partner at Visible Earth (2012-2017)
- Partner at Hedge House Partners LLP (2011-2014)
- Head of Marketing at Emergent Asset Management (2007-2011) and other marketing roles in finance-related firms.13
Education
Christie holds a BA(Hons) in European Business from Manchester Metropolitan University and a Maitrise in International Business from Université de Savoie.13
Vision and Impact
Paul is passionate about leveraging technology to improve global healthcare systems, particularly in underserved regions. He emphasizes the importance of conscious capitalism, which seeks to balance stakeholder interests while pursuing business opportunities. His vision is to democratize healthcare access through innovative diagnostic technologies that empower individuals to manage their health proactively.123